Norgesic Shortage Update: What Patients Need to Know in 2026

If you take Norgesic (orphenadrine/aspirin/caffeine) for acute muscle pain and you've been struggling to fill your prescription, you're probably wondering: is there a Norgesic shortage? The answer requires some nuance — and understanding the difference between an official FDA drug shortage and a practical availability problem is key to knowing what to do next.

Is Norgesic on the FDA Drug Shortage List in 2026?

No. As of 2026, Norgesic (orphenadrine citrate/aspirin/caffeine) is not listed on the FDA's official drug shortage database. This means there is no declared manufacturing or supply chain disruption affecting the medication at the federal level. The drug is being produced and distributed.

However — and this is crucial — "not in shortage" does not mean "easy to find." Norgesic's challenging availability stems from structural factors in how it's distributed, not from supply chain failures.

Why Patients Experience Norgesic As a 'Shortage' Drug

Here's why so many patients experience Norgesic availability the same way they'd experience a shortage drug — even though it technically isn't one:

Specialty-only distribution: Norgesic is available exclusively through a specialty pharmacy network. Standard retail pharmacies (CVS, Walgreens, Rite Aid, Walmart) cannot order it through their standard wholesalers.

Generic discontinuations: Some generic versions of orphenadrine/aspirin/caffeine have been discontinued by their manufacturers over the years, reducing the number of alternative sources available at retail.

Brand name changes: The higher-dose form originally known as Norgesic Forte (50mg/770mg/60mg) was rebranded as Orphengesic Forte. Patients searching specifically for "Norgesic Forte" by name may be told it's unavailable — because the name changed, not because the drug disappeared.

Insurance friction: Insurance formularies vary widely in how they cover Norgesic. Some plans require step therapy or prior authorization, which creates delays that feel like unavailability even when supply is adequate.

A Brief History of Norgesic's Availability

The original Norgesic brand was manufactured by Riker Laboratories (later acquired by Bausch Health/Bausch & Lomb). The Norgesic Forte formulation was later discontinued under the original labeler and the brand was eventually revived by Galt Pharmaceuticals with a specialty dispensing model.

Galt has also marketed the same formulations under the Orphengesic and Orphengesic Forte brand names. The specialty pharmacy model they chose — through Sterling Specialty Pharmacy and the Galt Central Fulfillment Pharmacy — is designed to control pricing and ensure patients get it affordably (the $30 cash-pay option), but it comes at the cost of widespread retail availability.

What's the Current Status of Norgesic in 2026?

FDA shortage status: Not listed — no manufacturing shortage

Retail availability: Limited — not stocked at major retail chains

Specialty pharmacy: Available through Galt's network with mail delivery nationwide

Generic availability: Inconsistent; some forms available at select independent pharmacies

Affordability: $0 for eligible insured; $30 for 60 tabs uninsured via Galt PAP

What Should Patients Do in 2026?

The most important thing is not to assume your prescription is unfillable just because your local pharmacy can't do it. Here's what to do:

Search with medfinder: Use medfinder.com to have pharmacies in your area checked for availability

Ask your prescriber: Request that they route the prescription to Sterling Specialty Pharmacy or enroll you in Galt's PAP

Check for Orphengesic: Ask pharmacies if they carry Orphengesic (same drug, different name) — some stock it independently

Discuss alternatives: Review Norgesic alternatives like cyclobenzaprine with your doctor if access remains a problem

Bottom Line

Norgesic is not in an FDA-declared shortage in 2026, but its specialty-only distribution makes it feel like one to many patients. The medication is available — just not at your corner pharmacy. Use the right channels and you can access it, often at a very reasonable cost through Galt's assistance programs.